 The trial is a Prospective, Multicentric, Randomized, Two Arm, Open label Phase III study to Assess Efficacy and Safety of Infusion of Amphomul Amphotericin B Emulsion as Compared to Liposomal Amphotericin B in Patients of Visceral Leishmaniasis Kala azarwho are either treatment naive or treatment resistant to other antileishmanial drugs. 